DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Sanchorawala V, Sarosiek S, Sloan JM. , et al.
Safety and tolerability of daratumumab in patients with relapsed light chain (AL) amyloidosis: preliminary results of a phase II study.
Blood 2017;
130: 507
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.